ONCE - Spark Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $119.38. This is a potential upside of $5.81 (5.12%) from yesterday's end of day stock price of $113.57.

Spark Therapeutics's activity chart (see below) currently has 84 price targets and 58 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 96.5% with an average time for these price targets to be met of 199.31 days.

Most recent stock forecast was given by GENA WANG from BARCLAYS on 25-Mar-2019. First documented stock forecast 24-Feb-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$74

$-39.57 (-34.84%)

5 years 7 months 27 days ago
(25-Mar-2019)

6/7 (85.71%)

$-39.53 (-34.82%)

203

Hold

$80

5 years 7 months 27 days ago
(25-Mar-2019)

5/5 (100%)

$23.99 (42.83%)

375

Hold

$65

$-48.57 (-42.77%)

$65

5 years 8 months 25 days ago
(27-Feb-2019)

5/6 (83.33%)

$-48.4 (-42.68%)

212

Hold

$72

5 years 8 months 26 days ago
(26-Feb-2019)

6/6 (100%)

$16.24 (29.12%)

280

Hold

5 years 8 months 27 days ago
(25-Feb-2019)

6/6 (100%)

$46.99 (83.90%)

465

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ONCE (Spark Therapeutics) average time for price targets to be met?

On average it took 199.31 days on average for the stock forecasts to be realized with a an average price target met ratio 96.5

Which analyst has the current highest performing score on ONCE (Spark Therapeutics) with a proven track record?

ELEMER PIROS

Which analyst has the most public recommendations on ONCE (Spark Therapeutics)?

Elemer Piros works at BENCHMARK and has 6 price targets and 6 ratings on ONCE

Which analyst is the currently most bullish on ONCE (Spark Therapeutics)?

Phil Nadeau with highest potential upside - $0

Which analyst is the currently most reserved on ONCE (Spark Therapeutics)?

David Nierengarten with lowest potential downside - -$71.13

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?